
U.S. Evidence Snapshot: Medtech Saves Lives
U.S. life expectancy has reached its highest level in history. Age-adjusted death rates for the leading causes of death dropped from 2023 to 2024, according to preliminary CDC data.
Our experts are continually producing new and valuable materials for the medtech community.

Compliance
AdvaMed® has developed revisions to the AdvaMed® Code of Ethics to address evolving compliance and legal standards, account for innovative value-based care arrangements, and incorporate additional provisions on risk areas specific to medical technology companies.

U.S. life expectancy has reached its highest level in history. Age-adjusted death rates for the leading causes of death dropped from 2023 to 2024, according to preliminary CDC data.

In this AdvaMed® Comment Letter to FDA, AdvaMed responds to the agency’s draft guidance on the electronic submission template (eSTAR) for premarket approval (PMA) applications. With eSTAR set to become…


BCG explores how AI is transforming medtech commercial operations, from customer engagement and sales to pricing and service.

Mass Tort TV Ad Trend – Q3 2026 AdvaMed’s latest quarterly report examines trends in medical device mass tort television advertising, including changes in advertising volume, estimated spending, and the…
AdvaMed® members receive full access to our library of medtech resources. Become a member to receive this and countless other benefits.